Table 5.
Physician-assessed median PFS by subgroup
| Subgroup | Median PFS (95% CI), days |
|---|---|
| Overall | 92 (86–101) |
| Gender | |
| Male | 87 (79–99) |
| Female | 100 (90–115) |
| Age, years | |
| <65 | 97 (87–113) |
| ≥65 | 89 (80–100) |
| Metastatic sitesa | |
| Liver | 69 (63–79) |
| Peritoneum | 99 (78–114) |
| Lymph nodes | 92 (79–106) |
| Lung | 91 (69–105) |
| Number of additional affected organs | |
| 0 | 176 (148–213) |
| <2 | 87 (79–94) |
| ≥3 | 63 (53–89) |
| Smoking history | |
| Yes | 91 (85–97) |
| No | 92 (84–105) |
| Rash | |
| Grade 0–1 | 85 (76–91) |
| Grade 2 | 125 (110–152) |
PFS, progression-free survival.
aPatients may have multiple metastases.